CFTR and cystic fibrosis: Analysis of these cells shows great promise to study the role of unique genetic modifiers in CFTR activity [49–51] especially since treatment of the CF-iPS-derived airway epithelial cells with a small molecule compound, C18, resulted in partial correction of the CFTR protein in the plasma membrane, suggesting that these cells could be used to model CF in vitro.